Sense Proteomic Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

Sense Proteomic General Information

Description

Developer of proprietary technology to discover and commercialise auto antibody biomarkers. The company offers biomarker panels for use with cancer and autoimmune disease patients.

Contact Information

Formerly Known As
Sensetherapeutic Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Unit 4
  • The Switchback Gardner Road
  • Maidenhead SL6 7RJ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Unit 4
  • The Switchback Gardner Road
  • Maidenhead SL6 7RJ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sense Proteomic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sense Proteomic‘s full profile, request access.

Request a free trial

Sense Proteomic Patents

Sense Proteomic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014195730-A2 Auto-antigen biomarkers for lupus Inactive 07-Jun-2013
WO-2014195730-A3 Auto-antigen biomarkers for lupus Inactive 07-Jun-2013
GB-201310216-D0 Sle(iv): auto-antigen biomarkers for lupus Inactive 07-Jun-2013
GB-201217288-D0 Slelll: auto-antigen biomarkers for lupus Inactive 27-Sep-2012
EP-2880445-A1 Auto-antigen biomarkers for lupus Inactive 02-Aug-2012 G01N33/564
To view Sense Proteomic’s complete patent history, request access »

Sense Proteomic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sense Proteomic Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sense Proteomic‘s full profile, request access.

Request a free trial

Sense Proteomic FAQs

  • When was Sense Proteomic founded?

    Sense Proteomic was founded in 1998.

  • Where is Sense Proteomic headquartered?

    Sense Proteomic is headquartered in Maidenhead, United Kingdom.

  • What is the size of Sense Proteomic?

    Sense Proteomic has 10 total employees.

  • What industry is Sense Proteomic in?

    Sense Proteomic’s primary industry is Drug Discovery.

  • Is Sense Proteomic a private or public company?

    Sense Proteomic is a Private company.

  • What is Sense Proteomic’s current revenue?

    The current revenue for Sense Proteomic is .

  • Who are Sense Proteomic’s investors?

    Apax Partners, Oxford Spin-out Equity Management, SoleGreen, University of Cambridge, and University of Oxford Endowment have invested in Sense Proteomic.

  • When was Sense Proteomic acquired?

    Sense Proteomic was acquired on 17-Mar-2009.

  • Who acquired Sense Proteomic?

    Sense Proteomic was acquired by Oxford Gene Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process